Douglas Flora, Executive Medical Director of Yung Family Cancer Center at St. Elizabeth Healthcare, President-Elect of the Association of Cancer Care Centers, and Editor in Chief of AI in Precision Oncology, shared a post on LinkedIn:
“When the Swedish Embassy Becomes a Laboratory for the Future of Cancer Care
‘In the space between urgency and care, innovation finds its conscience.’
Yesterday at the Swedish Embassy was a reminder of what’s possible when we bring the right people together around shared purpose.
Representing ACCC (Association of Cancer Care Centers) as President-Elect, I joined leaders from HHS, the American Cancer Society, ASCO, AACR, Friends of Cancer Research, the Personalized Medicine Coalition, valued industry partners, and others for a roundtable on ‘Life Science Innovation Through Artificial Intelligence’ to explore the transatlantic potential for responsible AI adoption in oncology.
What made it special wasn’t just the distinguished participants or the elegant setting at the Embassy’s official dining room. It was the quality of the conversation. We discussed how to accelerate the creation of novel, patient-centric ecosystems that can catalyze partnerships across academia, industry, and policy to enable scalable impact – recognizing that getting this right requires both urgency and care.
Special thanks to Dr. Jorge Reis-Filho, Dr. Faisal Mahmood, and Hebe Middlemiss for leading thoughtful discussions about what careful cooperation across borders can achieve. And to our gracious hosts at the Embassy of Sweden, for creating space for this kind of dialogue.
The real work, of course, happens after events like these – when ideas become action. But days like this matter. They remind us that the most important innovations in cancer care won’t come from technology alone, but from bringing together people who understand that AI’s highest purpose is making care more human.
The bonus few hours of Christmas shopping in a snowy Georgetown didn’t hurt either.”
More posts featuring Douglas Flora.
